Treatment of Epstein Barr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens
Chellapandian, DeepakBabu, Das, Rupali, Zelley, Kristin, Wiener, Susan J., Zhao, Huaqing, Teachey, David T., Nichols, Kim E., Hale, Gregory, Minkov, Milen, Karlhuber, Susanne, Weinstein, Joanna L., Weitzman, Sheila, Moshous, Despina, Fischer, Alain, Jeng, Michael, Henry, Michael, Haupt, Riccardo, Svahn, Joanna, Zapotocka, Ester, Wolfson, Julie, Yacobovich, Joanne, Van Laar, Jan A.M., Talano, Julie, Astigarraga, Itziar, Beutel, Karin, Berglöf, Elisabet, Henter, Jan‐Inge, Imashuku, Shinsaku, Ho, Marco Hok‐kung, Fraser, Chris, Greene Welch, Jennifer, Kitchen, Brenda, Jasty, Rama, Degar, Barbara A., Gunnes, Maria Winther, McMahon, Corrina, Garrington, Timothy, Filipovich, Alexandra H., Jordan, Michael B., Bleesing, Jacob J., Marsh, Rebecca A.
Published in British journal of haematology (01.08.2013)
Published in British journal of haematology (01.08.2013)
Get full text
Journal Article